VivoSeq
Other

Small for Gestational Age

12

Pipeline Programs↗

4

Active Trials↗

10

Companies Involved↗

Small for gestational age is an emerging landscape with 12 programs across 10 companies. The most active players are EMD Serono, Xiamen Amoytop Biotech Co., Ltd., Changchun GeneScience Pharmaceutical Co., Ltd.. 2 therapies are approved with 3 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

41/100

Pipeline Velocity

15/100

Mech. Concentration

50/100

Completion Rate

90/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

EMD Serono logo

EMD Serono

1 program

Phase 2X

Xiamen Amoytop Biotech Co., Ltd.

1 program

Phase 3Changchun GeneScience Pharmaceutical Co., Ltd. logo

Changchun GeneScience Pharmaceutical Co., Ltd.

3 programs

Phase 3Merck & Co. logo

Merck & Co.

2 programs

Phase 3Novartis logo

Novartis

1 program

ApprovedPfizer logo

Pfizer

4 programs

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

26

clinical trials

Completed19 · 73%
Recruiting3 · 12%
Terminated2 · 8%
Unknown status1 · 4%
Active, not recruiting1 · 4%

Clinical Trials

Trial Activity

26 trials

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.
Recruiting·RRabin Medical Center·Phase 3·NCT07226089·254 enrolled
The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age
Recruiting·XXiamen Amoytop Biotech Co., Ltd.·Phase 3·NCT07309562·141 enrolled
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
Recruiting·Changchun GeneScience Pharmaceutical Co., Ltd. logoChangchun GeneScience Pharmaceutical Co., Ltd.·Phase 2·NCT07260500·72 enrolled
Targeting Strategies of Antenatal Balanced Energy and Protein Supplementation in Addis Ababa, Ethiopia
Active, not recruiting·HHarvard School of Public Health (HSPH)·Preclinical·NCT06125860·6,750 enrolled
Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)
Completed·Novo Nordisk logoNovo Nordisk·Phase 3·NCT00184717·98 enrolled
Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA)
Completed·Novartis logoNovartis·Phase 4·NCT00537914·278 enrolled
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
Completed·Novo Nordisk logoNovo Nordisk·Phase 3·NCT00557336·160 enrolled
French National Registry of Children Born Small for Gestational Age Treated With Somatropin
Completed·Novo Nordisk logoNovo Nordisk·N/A·NCT01578135·291 enrolled
Treatment Of Children With Short Stature At An Age Of 3-7 Years Who Were Born Small For Gestational Age
Completed·Pfizer logoPfizer·Phase 3·NCT00174408·110 enrolled
Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)
Completed·Pfizer logoPfizer·Phase 4·NCT01859949·62 enrolled
Trial of Nutritional Supplementation in Infants Born Small for Gestational Age
Completed·IInstitute of Child Health·N/A·NCT00134771
Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
Completed·Novo Nordisk logoNovo Nordisk·Phase 4·NCT00519844·5 enrolled
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
Completed·Pfizer logoPfizer·Phase 3·NCT00174421·36 enrolled
Long Term Use of Somatropin in Patients Small for Gestational Age
Completed·Pfizer logoPfizer·N/A·NCT00793325·920 enrolled
Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age Fetuses
Completed·—·N/A·NCT04161989·80 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)